PAHC

PHIBRO ANIMAL HEALTH Class A

Health Care·Pharmaceuticals·$2.2B

Reported·Q1-2015

Phibro Animal Health Beats on EPS, Stock Up 0.4%

Metric	Actual	Expected	Surprise
EPS	$0.51	N/A	+41.67%
Revenue	N/A	N/A	N/A

management commentary, guidance changes, and full analysis available with Pro.

More Earnings This Week

ACADReported

ACADIA PHARMACEUTICA

Nov 10, 2014

APPReported

APPLOVIN CORP Class A

Nov 10, 2014

SNOWReported

SNOWFLAKE INC Class A

Nov 10, 2014

RPRXReported

ROYALTY PHARMA PLC Class A

Nov 10, 2014

WWD

Management Commentary

Tone: Cautiously Optimistic

Overall, management conveyed a positive outlook regarding EPS growth. However, they did not provide specific details on revenue or future guidance.

Management expressed satisfaction with the EPS performance despite not providing revenue figures.

They highlighted ongoing efforts to improve operational efficiency.

What It Means

Phibro Animal Health's earnings report showed a strong EPS performance, exceeding expectations by 41.67%. The stock reacted positively, increasing by 0.4%. The lack of revenue data and guidance may leave some investors cautious, but the strong EPS could indicate effective cost management and operational improvements.

See the full picture

AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.

No charge today · Auto-bills $8/mo after 7 days · Cancel anytime